Codexis, Inc.

📍 Redwood City, United States🗓 Founded 2002👥 257 employees💰 Last funded Apr 2025
Biotechnology Research🌐 codexis.com
Website LinkedIn
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2002
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Codexis, Inc.?
Codexis, Inc. has 2 investors on record on gritt.io.
When did Codexis, Inc. last raise funding?
The most recent investment in Codexis, Inc. recorded on gritt.io was in April 2025.
When was Codexis, Inc. founded?
Codexis, Inc. was founded in 2002.
What industry is Codexis, Inc. in?
Codexis, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Codexis, Inc. based?
Codexis, Inc. is headquartered in Redwood City, United States.